Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion

Canadian Journal of Cardiology

Volumn 16, Issue 1, 2000, Pages 83-85

  Bertrand, Olivier F ^a   Meerkin, David ^a   De Guise, Pierre ^a   Crépeau, Jacques ^a   Bourassa, Martial G ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Angioplasty; Platelet aggregation inhibitors; Stents; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; TICLOPIDINE;

ACUTE HEART INFARCTION; ARTERIOGRAPHY; ARTERY OCCLUSION; ARTICLE; CASE REPORT; DOSE RESPONSE; HEART CATHETERIZATION; HUMAN; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RIGHT CORONARY ARTERY; STENT; THROMBOEMBOLISM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; STENTS;

EID: 0033970078     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
3. Bertrand OF, Legrand V, Bilodeau L, Martinez CA, Kulbertus HE. Emergency coronary stenting with Wiktor stent. Immediate and late results. J Invasive Cardiol 1997;9:2-9.
4. Hasdai D, Garrat KN, Holmes DR, Berger PB, Schwartz RS, Bell MR. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol 1996;28:361-7.
5. Topol EJ, Califf RM, Weismann HF, et al. Randomized trial of coronary intervention with antibody against platelet IIb-IIIa integrin for reduction of clinical restenosis. Lancet 1994;343:881-6.
6. Theroux P. Oral inhibitors of platelet membrane receptor glycoprotein Ilb/IIIa in clinical cardiology: issues and opportunities. Am Heart J 1998;135:S107-12.
7. Platelet glycoprotein Ilb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997;336:1689-96.
8. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa inhibitor for stenting. Lancet 1998;352:87-92.
9. Gawaz M, Neumann FJ, Ott I, May A, Rudiger S, Schomig A. Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis. Coron Artery Dis 1997;8:121-8.
10. Jeong M, Owen W, Staab M, et al. Porcine model of stent thrombosis: platelets are the primary component of acute stent closure. Cathet Cardiovasc Diagn 1996;38:38-43.
11. Henry P, Boughalem K, Rinaldi JP, et al. Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation. Cathet Cardiovasc Diagn 1998;43:105-7.
12. Berkompas DC. Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis. Cathet Cardiovasc Diagn 1998;45:272-4.